Request Trial

Biotech news

Reset all filters
Geography
Company
Refine search
China’s new policies on foreign investment in healthcare and biotech
Asia
China’s new policies on foreign investment in healthcare and biotech
Free trade zones in Beijing, Shanghai, Guangdong, and Hainan are designed to attract capital into China’s fast-growing healthcare sectors, says Li Mi of Lusheng.   7 November 2024
Startup CFO’s betrayal is a lesson in preparing for the worst
Americas
Startup CFO’s betrayal is a lesson in preparing for the worst
Well-drafted contracts and ironclad tech security can save time and money when an ex-employee steals IP ‘like sugar packets in Starbucks’, finds Tom Phillips.   7 November 2024
Sanofi subsidiary fends off $450m trade secrets case
Americas
Sanofi subsidiary fends off $450m trade secrets case
A jury in Delaware unanimously dismissed all allegations of misappropriation against Inhibrx, a Sanofi-owned biotech firm | Case stemmed from a previous arbitration involving the chief scientific officer of Inhibrx | Jury found no evidence supporting opponents claims, awarding the plaintiff $0 damages.   5 November 2024
Americas
Pfizer infringed haemophilia therapy patent, says court
UK High Court judge unconvinced by Pfizer that uniQure’s patent is invalid | Companies in dispute over patents covering haemophilia B therapies in the US, Canada and UK   29 October 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
Regeneron loses bid to block Eylea copy at US appeals court | Biotech says decision ‘not the final word’ in litigation   24 October 2024
Americas
10x Genomics counsel: ‘Winning cases is a top priority’
10x Genomics senior director of IP and litigation shares her team's tasks, how she’s handling UPC litigation, and why sometimes she wants a ‘gut answer’ from externals, finds Marisa Woutersen.   22 October 2024
Americas
HR, lobbying and business strategy…all in a day’s work for today’s counsel
In-house pharma and biotech lawyers are taking on broader roles, from handling regulatory issues to corporate strategy—and outside counsel can help, finds Marisa Woutersen.   22 October 2024
Americas
LSPN Fall: Gilead GC shares top drafting tips
At LSPN Fall North America, in-house counsel offered guidance on how to nail the perfect patent application. Marisa Woutersen reports.   17 October 2024
Americas
LSPN Fall: Why Big Pharma is facing 'a balancing act'
As the pharma sector grapples with legal and regulatory upheaval, LSPN Fall North America explored the need for companies to reassess their patent strategies. Marisa Woutersen reports.   17 October 2024
Americas
Novo Nordisk targets Canada’s largest generics maker over diabetes drug
Danish pharma company asserts 10 patents for drug that improves blood sugar levels in Type 2 diabetes patients | Like Novo’s Ozempic, the disputed drug can be used off-label to achieve weight loss.   15 October 2024